Aleksander, P., Krzysztof, N., Adam, W., Sławomir, D., Andrzej, J., Agnieszka, K.C., Jacek, K., Jacek, L., Maciej, L., Andrzej, T., Wojciech, W., Magdalena, K., Marcin, A., Andrzej, W., Jacek, W., & Robert, G. (2026). The expert position of the Polish Cardiac Society, the Polish Society of Hypertension, and the Polish Society of Nephrology on renal denervation.. Kardiologia polska. https://doi.org/10.33963/v.phj.112318
Aleksander P, Krzysztof N, Adam W, Sławomir D, Andrzej J, Agnieszka KC, et al. The expert position of the Polish Cardiac Society, the Polish Society of Hypertension, and the Polish Society of Nephrology on renal denervation.. Kardiologia polska. 2026; doi: 10.33963/v.phj.112318
Aleksander P, Krzysztof N, Adam W, et al. The expert position of the Polish Cardiac Society, the Polish Society of Hypertension, and the Polish Society of Nephrology on renal denervation.[J]. Kardiologia polska. 2026. DOI: 10.33963/v.phj.112318.
@article{aleksander2026,
author = {Prejbisz Aleksander and Narkiewicz Krzysztof and Witkowski Adam and Dobrzycki Sławomir and Januszewicz Andrzej and Kapłon-Cieślicka Agnieszka and Kądziela Jacek and Legutko Jacek and Lesiak Maciej and Tykarski Andrzej and Wojakowski Wojciech and Krajewska Magdalena and Adamczak Marcin and Więcek Andrzej and Wolf Jacek and Gil Robert},
title = {The expert position of the Polish Cardiac Society, the Polish Society of Hypertension, and the Polish Society of Nephrology on renal denervation.},
journal = {Kardiologia polska},
year = {2026},
doi = {10.33963/v.phj.112318},
note = {PMID: 42089223},
}
TY - JOUR AU - Prejbisz Aleksander AU - Narkiewicz Krzysztof AU - Witkowski Adam AU - Dobrzycki Sławomir AU - Januszewicz Andrzej AU - Kapłon-Cieślicka Agnieszka AU - Kądziela Jacek AU - Legutko Jacek AU - Lesiak Maciej AU - Tykarski Andrzej AU - Wojakowski Wojciech AU - Krajewska Magdalena AU - Adamczak Marcin AU - Więcek Andrzej AU - Wolf Jacek AU - Gil Robert TI - The expert position of the Polish Cardiac Society, the Polish Society of Hypertension, and the Polish Society of Nephrology on renal denervation. T2 - Kardiologia polska PY - 2026 DO - 10.33963/v.phj.112318 AN - PMID:42089223 ER -
Renal denervation is an innovative method of treating hypertension (HT), used in clinical practicefor about a decade. The pathophysiological basis of this method derives from the role of efferentand afferent fibers of the sympathetic nervous system, entering and leaving the kidneys, in thedevelopment of HT, especially treatment-resistant HT. Initial clinical trials have suggested the highefficacy of denervation in the treatment of patients with resistant HT. However, the results of theSymplicity HTN-3 trial, which introduced a sham procedure as a control, undermined these hopes,although this trial was criticized for its methodology. Recent research, using latest-generation cathetersand more stringent protocols, confirms a significant reduction in blood pressure in patientsafter this procedure. Renal denervation should be considered in patients with HT (after excludingall hormonal causes and ischemic etiology) that is resistant to pharmacological treatment. Pseudoresistance, e.g., caused by so-called white-coat HT, should be ruled out. Every patient should complete24 hours ambulatory blood pressure monitoring. Lack of cooperation between the patientand the physician, irregular use of antihypertensive medications, and non-compliance with othertherapeutic recommendations should also be excluded. However, the condition for the successof renal denervation is the precise determination of patient eligibility and the performance of theprocedure in specialized centers with appropriate experience.